• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Gilead to buy cancer drugmaker Immunomedics for $21B

cafead

Administrator
Staff member
  • cafead   Sep 13, 2020 at 10:33: PM
via Gilead on Sunday reached a deal to buy Immunomedics for approximately $21 billion, agreeing to pay more than double the New Jersey drugmaker's market value to gain access to its recently approved breast cancer medicine.

article source
 

<